Behavior of sartans (antihypertensive drugs) in wastewater treatment plants, their occurrence and risk for the aquatic environment
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Behavior of sartans (antihypertensive drugs) in wastewater treatment plants, their occurrence and risk for the aquatic environment
Authors
Keywords
Pharmaceuticals, Mixture toxicity, Ecotoxicity, Risk assessment, Elimination, Monitoring
Journal
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
Volume 21, Issue 18, Pages 10830-10839
Publisher
Springer Nature
Online
2014-06-05
DOI
10.1007/s11356-014-3060-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of micropollutants in municipal wastewater: Ozone or powdered activated carbon?
- (2013) Jonas Margot et al. SCIENCE OF THE TOTAL ENVIRONMENT
- Occurrence and fate of the angiotensin II receptor antagonist transformation product valsartan acid in the water cycle – A comparative study with selected β-blockers and the persistent anthropogenic wastewater indicators carbamazepine and acesulfame
- (2013) Karsten Nödler et al. WATER RESEARCH
- Hospital Wastewater Treatment by Membrane Bioreactor: Performance and Efficiency for Organic Micropollutant Elimination
- (2012) Lubomira Kovalova et al. ENVIRONMENTAL SCIENCE & TECHNOLOGY
- Analysis of 100 pharmaceuticals and their degradates in water samples by liquid chromatography/quadrupole time-of-flight mass spectrometry
- (2012) Imma Ferrer et al. JOURNAL OF CHROMATOGRAPHY A
- Pharmaceuticals in the Environment
- (2010) Klaus Kümmerer Annual Review of Environment and Resources
- Occurrence and fate of the human pharmaceutical metabolite ritalinic acid in the aquatic system
- (2010) Marion Letzel et al. CHEMOSPHERE
- High-Throughput Identification of Microbial Transformation Products of Organic Micropollutants
- (2010) Damian E. Helbling et al. ENVIRONMENTAL SCIENCE & TECHNOLOGY
- Structure-Based Interpretation of Biotransformation Pathways of Amide-Containing Compounds in Sludge-Seeded Bioreactors
- (2010) Damian E. Helbling et al. ENVIRONMENTAL SCIENCE & TECHNOLOGY
- A tiered procedure for assessing the formation of biotransformation products of pharmaceuticals and biocides during activated sludge treatment
- (2010) Susanne Kern et al. JOURNAL OF ENVIRONMENTAL MONITORING
- Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater
- (2010) Beate I. Escher et al. WATER RESEARCH
- Discharge of pharmaceutical products (PPs) through a conventional biological sewage treatment plant: MECs vs PECs?
- (2009) C.M. Coetsier et al. ENVIRONMENT INTERNATIONAL
- Illicit drugs and pharmaceuticals in the environment – Forensic applications of environmental data, Part 2: Pharmaceuticals as chemical markers of faecal water contamination
- (2009) Barbara Kasprzyk-Hordern et al. ENVIRONMENTAL POLLUTION
- Fate of pharmaceuticals and personal care products in wastewater treatment plants – Conception of a database and first results
- (2009) C. Miège et al. ENVIRONMENTAL POLLUTION
- Elimination of Organic Micropollutants in a Municipal Wastewater Treatment Plant Upgraded with a Full-Scale Post-Ozonation Followed by Sand Filtration
- (2009) Juliane Hollender et al. ENVIRONMENTAL SCIENCE & TECHNOLOGY
- The presence of pharmaceuticals in the environment due to human use – present knowledge and future challenges
- (2009) Klaus Kümmerer JOURNAL OF ENVIRONMENTAL MANAGEMENT
- Occurrence and fate of pharmaceutical products and by-products, from resource to drinking water
- (2008) S. Mompelat et al. ENVIRONMENT INTERNATIONAL
- The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK
- (2008) Barbara Kasprzyk-Hordern et al. WATER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started